[go: up one dir, main page]

BR9909233A - Formulações sólidas de cetirizina que se decompõem rapidamente - Google Patents

Formulações sólidas de cetirizina que se decompõem rapidamente

Info

Publication number
BR9909233A
BR9909233A BR9909233-6A BR9909233A BR9909233A BR 9909233 A BR9909233 A BR 9909233A BR 9909233 A BR9909233 A BR 9909233A BR 9909233 A BR9909233 A BR 9909233A
Authority
BR
Brazil
Prior art keywords
cetirizine
solid
formulations
decompose rapidly
effervescent
Prior art date
Application number
BR9909233-6A
Other languages
English (en)
Inventor
Wolfram Tritthart
Mario Andre Maildorf Piskernig
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of BR9909233A publication Critical patent/BR9909233A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>"FORMULAçõES SóLIDAS DE CETIRIZINA QUE SE DECOMPõEM RAPIDAMENTE"<D>. A presente invenção refere-se a formulações efervescentes, para a aplicação oral, as quais contêm cetirizina ou seus sais farmaceuticamente compatíveis, um substrato efervescente consistindo em pelo menos um ácido edível orgânico e/ou seus sais, carbonatos ou hidrogenocarbonatos de metais alcalinos e/ou de metais alcalino-terrosos e eventualmente substâncias auxiliares farmaceuticamente aceitáveis.
BR9909233-6A 1998-03-31 1999-03-20 Formulações sólidas de cetirizina que se decompõem rapidamente BR9909233A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (1)

Publication Number Publication Date
BR9909233A true BR9909233A (pt) 2000-11-28

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909233-6A BR9909233A (pt) 1998-03-31 1999-03-20 Formulações sólidas de cetirizina que se decompõem rapidamente

Country Status (31)

Country Link
US (1) US6245353B1 (pt)
EP (1) EP1067904B1 (pt)
JP (1) JP2002509873A (pt)
KR (1) KR100653568B1 (pt)
CN (1) CN1136838C (pt)
AR (1) AR018828A1 (pt)
AT (1) ATE209899T1 (pt)
AU (1) AU750140B2 (pt)
BG (1) BG64741B1 (pt)
BR (1) BR9909233A (pt)
CA (1) CA2326809C (pt)
CY (1) CY1107331T1 (pt)
CZ (1) CZ300704B6 (pt)
DE (2) DE19814256A1 (pt)
DK (1) DK1067904T3 (pt)
ES (1) ES2168013T3 (pt)
HK (1) HK1036217A1 (pt)
HU (1) HU227477B1 (pt)
IL (1) IL138606A (pt)
NO (1) NO329071B1 (pt)
NZ (1) NZ506988A (pt)
PL (1) PL191266B1 (pt)
PT (1) PT1067904E (pt)
RU (1) RU2216318C2 (pt)
SI (1) SI1067904T1 (pt)
SK (1) SK284476B6 (pt)
TR (1) TR200002809T2 (pt)
TW (1) TWI233808B (pt)
UA (1) UA57615C2 (pt)
WO (1) WO1999049843A1 (pt)
ZA (1) ZA200005134B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415643C (en) 2000-07-17 2010-11-16 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceutical composition for oral use with improved absorption
MXPA04006775A (es) * 2002-01-15 2004-11-10 Ucb Farchim Sa Formulaciones.
ES2298540T3 (es) * 2002-04-04 2008-05-16 Pfizer Products Inc. Comprimido masticable agradable.
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
KR20070104884A (ko) 2004-11-24 2007-10-29 메드포인트 헬쓰케어 인크. 아젤라스틴을 포함하는 조성물 및 이의 사용 방법
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
CA2734691C (en) * 2008-09-05 2017-05-16 Mcneil-Ppc, Inc. Method for making cetirizine tablets
PE20120647A1 (es) * 2009-03-13 2012-05-31 Nucitec Sa De Cv Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
ES2541723T3 (es) 2012-06-12 2015-07-24 The Procter & Gamble Company Forma de dosificación efervescente
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
KR100198044B1 (ko) * 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
AU678561B2 (en) * 1992-10-09 1997-06-05 Procter & Gamble Company, The Pharmaceutical compositions and methods for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
EP0695175A1 (en) * 1993-04-30 1996-02-07 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
IL138606A0 (en) 2001-10-31
HU227477B1 (en) 2011-07-28
CZ20003481A3 (en) 2001-05-16
CN1136838C (zh) 2004-02-04
WO1999049843A1 (de) 1999-10-07
ES2168013T3 (es) 2002-05-16
HUP0102676A2 (hu) 2001-11-28
KR20010034718A (ko) 2001-04-25
CY1107331T1 (el) 2012-12-19
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
BG64741B1 (bg) 2006-02-28
AR018828A1 (es) 2001-12-12
NO329071B1 (no) 2010-08-16
PL191266B1 (pl) 2006-04-28
HK1036217A1 (en) 2001-12-28
US6245353B1 (en) 2001-06-12
ZA200005134B (en) 2000-12-21
SK284476B6 (sk) 2005-04-01
CA2326809A1 (en) 1999-10-07
DE59900501D1 (de) 2002-01-17
SI1067904T1 (en) 2002-04-30
DE19814256A1 (de) 1999-10-07
EP1067904A1 (de) 2001-01-17
NZ506988A (en) 2002-05-31
CA2326809C (en) 2008-11-18
EP1067904B1 (de) 2001-12-05
UA57615C2 (uk) 2003-06-16
DK1067904T3 (da) 2002-04-02
AU3925399A (en) 1999-10-18
HUP0102676A3 (en) 2002-12-28
CZ300704B6 (cs) 2009-07-22
TR200002809T2 (tr) 2000-12-21
BG104843A (en) 2001-07-31
NO20004722D0 (no) 2000-09-21
AU750140B2 (en) 2002-07-11
IL138606A (en) 2005-07-25
ATE209899T1 (de) 2001-12-15
PL343199A1 (en) 2001-07-30
JP2002509873A (ja) 2002-04-02
RU2216318C2 (ru) 2003-11-20
CN1295464A (zh) 2001-05-16
TWI233808B (en) 2005-06-11
SK14312000A3 (sk) 2001-07-10
KR100653568B1 (ko) 2006-12-05

Similar Documents

Publication Publication Date Title
BR9909233A (pt) Formulações sólidas de cetirizina que se decompõem rapidamente
WO1999063826A3 (de) Mittel zur bekämpfung von pflanzenschädlingen
UY27320A1 (es) Nuevas composiciones farmacéuticas
ES2164785T3 (es) Composiciones orales que contienen compuestos estannosos estabilizados.
BR9909266A (pt) Formulações efervescentes
YU23599A (sh) Stabilizovani antihistaminski sirup
BRPI9710554A (pt) Composição oral antiplaca.
AR016662A1 (es) Composicion y metodo para inhibir el crecimiento de microorganismos, la cual incluye hipobromito de sodio estabilizado e isotiazolonas.
BR9910494B1 (pt) composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo.
HUP0301240A3 (en) Pyridazine compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors and pharmaceutical compositions containing them
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
EP1222922A4 (en) METHOD FOR STABILIZING BENZIMIDAZOLE COMPOUNDS
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR0210348A (pt) Material polimérico, contendo um ácido latente
PT1408966E (pt) Combinações farmacêuticas sinergísticas para a prevenção ou tratamento da diabetes
AU2001268131A1 (en) Stabilized compositions containing oxygen-labile active agents
BR9904036A (pt) Combinação de ìons de zinco e vitamina c e processo de fabricação
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
WO2000039095A3 (en) Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
AU2001279633A1 (en) Device and method for cleaning and sanitizing a food reservoir
PE20000271A1 (es) Composicion farmaceutica de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
PT1093451E (pt) Composicoes solidas adequadas para administracao oral contendo sais nao-higroscopicos de l-carnitina e alcanoil-l-carnitinas

Legal Events

Date Code Title Description
TC Change of name
PC Transfer

Owner name: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG (DE)

TC Change of name
B25G Requested change of headquarter approved

Owner name: VIATRIS GMBH AND CO. KG (DE)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020050037237/RJ DE 17/05/2005.

B25D Requested change of name of applicant approved

Owner name: MEDA PHARMA GMBH AND CO. KG (DE)

Free format text: ALTERADO DE: VIATRIS GMBH AND CO. KG

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: A61K 9/46; C07D 241/04

Ipc: A61K 9/46 (2008.01), C07D 241/04 (2008.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI